Evidence map›Paper›PMID 32439031›Full record

ReviewJACC. Clinical electrophysiology2020

Autonomic Modulation of Cardiac Arrhythmias: Methods to Assess Treatment and Outcomes.

Stavros Stavrakis, Kanchan Kulkarni, Jagmeet P Singh, Demosthenes G Katritsis, Antonis A Armoundas

Open access · greenAbstract readReview
In one paragraph

Review in JACC. Clinical electrophysiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. ANTHEM-HFrEF: does early termination obscure a potential treatment signal?Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2026
    Article
  7. Ventricular tachycardia exit site location within myocardial reinnervation zones predicts hemodynamic stability in ischemic cardiomyopathy.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Baroreceptor reflex after pulmonary vein isolation assessed by tilt table test: adding another piece to the puzzle.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Stavros StavrakisHeart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Electronic address: Stavros-stavrakis@ouhsc.edu.
Kanchan KulkarniCardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jagmeet P SinghCardiology Division, Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts, USA.
Demosthenes G KatritsisHygeia Hospital, Athens, Greece.
Antonis A ArmoundasCardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. Electronic address: armoundas.antonis@mgh.harvard.edu.
Massachusetts General Hospital · USHygeia Hospital · GRUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TIMOTHY M VANWAGONER · 2013 to 2026
$68.2M
Prevention and Treatment of Ventricular TachyarrhythmiasR01HL135335 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2017 to 2020
$2.1M
Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillationR01HL161008 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Stavros Stavrakis · 2022 to 2026
$1.9M
A Medical-Grade Smart-Phone Based Monitoring System (Supplement)R21EB026164 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2018 to 2020
$668k
Utility of Vagal Stimulation to Prevent the Onset of Ventricular ArrhythmiasR21HL137870 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ARMOUNDAS, ANTONIS A · 2017 to 2018
$468k
Neuromodulation of Inflammation to Treat Heart Failure with Preserved Ejection FractionR21AG057879 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI STAVRAKIS, STAVROS · 2018 to 2019
$407k
American Heart Association-American Stroke Association 15MCPRP25790001NHLBI NIH HHS R01 HL135335NHLBI NIH HHS R01 HL161008NHLBI NIH HHS R21 HL137870NIA NIH HHS R21 AG057879NIBIB NIH HHS R21 EB026164NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

The autonomic nervous system plays a central role in the pathogenesis of multiple cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. As such, autonomic modulation represents an attractive therapeutic approach in these conditions. Notably, autonomic modulation exploits the plasticity of the neural tissue to induce neural remodeling and thus obtain therapeutic benefit. Different forms of autonomic modulation include vagus nerve stimulation, tragus stimulation, renal denervation, baroreceptor activation therapy, and cardiac sympathetic denervation. This review seeks to highlight these autonomic modulation therapeutic modalities, which have shown promise in early preclinical and clinical trials and represent exciting alternatives to standard arrhythmia treatment. We also present an overview of the various methods used to assess autonomic tone, including heart rate variability, skin sympathetic nerve activity, and alternans, which can be used as surrogate markers and predictors of the treatment effect. Although the use of autonomic modulation to treat cardiac arrhythmias is supported by strong preclinical data and preliminary studies in humans, in light of the disappointing results of a number of recent randomized clinical trials of autonomic modulation therapies in heart failure, the need for optimization of the stimulation parameters and rigorous patient selection based on appropriate biomarkers cannot be overemphasized.

Indexed as

Atrial FibrillationVagus Nerve StimulationAutonomic Nervous SystemHeartHumansTreatment Outcomealternansarrhythmiasautonomic modulationautonomic nervous systemheart rate variability

Identifiers

PMID32439031
PMCPMC7370838
OpenAlexW3024327193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.